全球精準醫療市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

全球精準醫療市場需求預計將從2023年的842.1億美元達到近1,698.8億美元的市場規模，2024-2032年研究期間複合年成長率為8.11%。

精準醫療，也稱為個人化醫療，是近年來快速成長的醫療保健領域的未來趨勢。精準醫學基於一個獨特的概念，即感染相同疾病的兩個人不需要對該疾病有相同的身體反應。但取決於周圍環境以及患者基因和症狀的影響。此外，它還取決於患者對特定疾病的反應能力，使醫生和研究人員能夠組織必要的治療。精準醫學主要包括系統生物學和全景組學，從分子層面檢查個別患者患病的原因。其次是使用濃縮藥物來解決個別患者的疾病。精準醫療提供了許多好處，例如根據患者需求和疾病類別量身定做的高效治療。此外，精準醫療可以降低治療成本，並有助於減少重複用藥。

市場動態

該市場的主要促進因素包括藥物及其伴隨診斷檢測的批准增加、DNA 的成本效益分析、癌症發病率的增加以及數據驅動的醫療保健的興起。此外，「多組學」在研究中的日益普及，以及高通量定序平台的滲透，也正在催生精準醫療場景。針對特定應用的管道中的標靶分子數量呈指數級成長，特別是在腫瘤學領域，在預測期內創造了新的機會。當前藥物發現價格的不斷上漲和監管要求的不斷提高增加了對個人化產品的需求。伴隨診斷的發展似乎提供了一套工具以及相關的臨床和生物學資訊來滿足不同製藥公司的需求。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球精準醫療市場的各個細分市場進行了包容性評估。精準醫療產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

精準醫療市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按申請

• 診斷（基因測試、基於生物標記的測試、深奧測試、其他測試）
• 治療藥物（抑制劑藥物、單株抗體、細胞和基因治療、抗病毒和抗逆轉錄病毒藥物、其他治療藥物）

按指示

• 腫瘤學
• 中樞神經系統疾病
• 免疫學
• 呼吸系統疾病
• 遺傳性疾病
• 皮膚病
• 其他適應症

依技術

• 基因組學
• 生物資訊學
• 巨量資料分析
• 生物標記檢測
• 高通量篩選
• 其他技術

按最終用戶

• 醫院
• 診斷實驗室
• 其他最終用戶

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲精準醫療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。精準醫療市場的主要參與者包括 Abbott Laboratories Inc.、Abbie Inc.、AstraZeneca Plc、BioMerieux SA、Bristol-Myers Squibb Company、Cepheid（Danaher Corporation）、EliLilly & Company、F. Hoffmann-La Roche、GlaxoSmithKline Plc、LaboraKline Plc Corporation Of America Holdings (Covance Inc.)、Myriad Genetics Inc.、Novartis AG、Pfizer Inc.、QIAGEN NV.、Quest Diagnostics、Takeda Pharmaceutical Company Limited、ThermFisher Scientific Inc.、Vyant Bio Inc. (Cancer Genetics Inc.) 。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：精準醫療 - 產業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 產業動態
• 波特五力分析
• 市場吸引力分析
  • 市場吸引力分析：依應用分類
  • 按指標進行的市場吸引力分析
  • 按技術分類的市場吸引力分析
  • 最終用戶的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原物料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷通路發展趨勢

第 5 章：全球精準醫療市場分析：依應用分類

• 概述：按應用
• 歷史與預測資料分析：按應用分類
• 診斷（基因測試、基於生物標記的測試、深奧測試、其他測試）
• 治療藥物（抑制劑藥物、單株抗體、細胞和基因治療、抗病毒和抗逆轉錄病毒藥物、其他治療藥物）

第 6 章：全球精準醫療市場分析：依適應症分類

• 按指示概述
• 按指示進行歷史和預測資料分析
• 腫瘤學
• 中樞神經系統疾病
• 免疫學
• 呼吸系統疾病
• 遺傳性疾病
• 皮膚病
• 其他適應症

第 7 章：全球精準醫療市場分析：依技術分類

• 依技術概述
• 透過技術進行歷史和預測數據分析
• 基因組學
• 生物資訊學
• 巨量資料分析
• 生物標記檢測
• 高通量篩選
• 其他技術

第 8 章：全球精準醫療市場分析：依最終使用者分類

• 最終用戶概述
• 最終用戶的歷史和預測數據分析
• 醫院
• 診斷實驗室
• 其他最終用戶

第 9 章：全球精準醫療市場分析：依地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區按國家銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳洲銷售分析
  • 東南亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲按國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 10 章：精準醫療公司的競爭格局

• 精準醫療市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 11 章：公司簡介

• 頂級公司市佔率分析
• 市場集中度
• Abbott Laboratories Inc.
• 公司概況
• 公司收入
• 產品
• 最新動態
• Abbie Inc.
• 公司概況
• 公司收入
• 產品
• 最新動態
• AstraZeneca Plc
• 公司概況
• 公司收入
• 產品
• 最新動態
• BioMerieux SA
• 公司概況
• 公司收入
• 產品
• 最新動態
• Bristol-Myers Squibb Company
• 公司概況
• 公司收入
• 產品
• 最新動態
• Cepheid (Danaher Corporation)
• 公司概況
• 公司收入
• 產品
• 最新動態
• EliLilly & Company
• 公司概況
• 公司收入
• 產品
• 最新動態
• F. Hoffmann-La Roche
• 公司概況
• 公司收入
• 產品
• 最新動態
• GlaxoSmithKline Plc
• 公司概況
• 公司收入
• 產品
• 最新動態
• Laboratory Corporation Of America Holdings (Covance Inc.)
• 公司概況
• 公司收入
• 產品
• 最新動態
• Myriad Genetics Inc.
• 公司概況
• 公司收入
• 產品
• 最新動態
• Novartis AG
• 公司概況
• 公司收入
• 產品
• 最新動態
• Pfizer Inc.
• 公司概況
• 公司收入
• 產品
• 最新動態
• QIAGEN NV.
• 公司概況
• 公司收入
• 產品
• 最新動態
• Quest Diagnostics
• 公司概況
• 公司收入
• 產品
• 最新動態
• Takeda Pharmaceutical Company Limited
• 公司概況
• 公司收入
• 產品
• 最新動態
• ThermFisher Scientific Inc.
• 公司概況
• 公司收入
• 產品
• 最新動態
• Vyant Bio Inc. (Cancer Genetics Inc.)
• 公司概況
• 公司收入
• 產品
• 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

The global demand for Precision Medicine Market is presumed to reach the market size of nearly USD 169.88 Billion by 2032 from USD 84.21 Billion in 2023 with a CAGR of 8.11% under the study period 2024-2032.

The precision medicine, also known as personalized medicines, is the upcoming trend in the healthcare sector that grows rapidly over the years. Precision medicine is based on a unique concept that defines, two people infected with the same disease don't need to have the same physical response toward the disorder. However, it depends on the surrounding environment and the influence of genes and symptoms of the patient. Moreover, it also depends on patients' ability to respond to that particular disease, enabling the doctors and researchers to organize the necessary treatment. Precision medicine mainly includes system biology and panomics to examine the reason for an individual patient's illness at the molecular level. Followed by the use of concentrated medications to address individual patient's ailments. Precision medicine offers many benefits, such as efficient treatment customized to patients' needs and disease categories. Moreover, precision medicine can reduce the cost of treatment and help decrease repeated administration of medications.

MARKET DYNAMICS

The market is mainly driven by increasing approval of the drug and its companion diagnostic assay, cost-effective profiling of DNA, increasing incidence of cancer, and the rise of data-driven healthcare. In addition, the rising use of "multi-omics" in research, along with the penetration of high-throughput sequencing platforms, is also surging up the precision medicine scenario. The number of targeted molecules in the pipeline for a specific application has been exponentially growing, specifically in oncology has created a new opportunity over the forecast period. The current escalating price of drug discovery and increasing regulatory requirements have increased the demand for an individualized product. The development of companion diagnostics appears to offer a set of tools and relevant clinical and biological information to address various pharmaceutical companies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Precision Medicine. The growth and trends of Precision Medicine industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Precision Medicine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

• Diagnostics (Genetic Tests, Biomarker Based Tests, Esoteric Tests, Other Tests)
• Therapeutics (Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, Other Therapeutics)

By Indication

• Oncology
• CNS Disorders
• Immunology
• Respiratory Diseases
• Genetic Disorders
• Skin Diseases
• Other Indications

By Technology

• Genomics
• Bioinformatics
• Big Data Analytics
• Biomarker Detection
• High Throughput Screening
• Other Technologies

By End-User

• Hospitals
• Diagnostic Laboratories
• Other End-Users

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Precision Medicine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Precision Medicine market include Abbott Laboratories Inc., Abbie Inc., AstraZeneca Plc, BioMerieux SA, Bristol-Myers Squibb Company, Cepheid (Danaher Corporation), EliLilly & Company, F. Hoffmann-La Roche, GlaxoSmithKline Plc, Laboratory Corporation Of America Holdings (Covance Inc.), Myriad Genetics Inc., Novartis AG, Pfizer Inc., QIAGEN NV., Quest Diagnostics, Takeda Pharmaceutical Company Limited, ThermFisher Scientific Inc., Vyant Bio Inc. (Cancer Genetics Inc.). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. PRECISION MEDICINE - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Application
  • 3.7.2 Market Attractiveness Analysis By Indication
  • 3.7.3 Market Attractiveness Analysis By Technology
  • 3.7.4 Market Attractiveness Analysis By End-User
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY APPLICATION

• 5.1. Overview By Application
• 5.2. Historical and Forecast Data Analysis By Application
• 5.3. Diagnostics (Genetic Tests, Biomarker Based Tests, Esoteric Tests, Other Tests) Historic and Forecast Sales By Regions
• 5.4. Therapeutics (Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, Other Therapeutics) Historic and Forecast Sales By Regions

6. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY INDICATION

• 6.1. Overview By Indication
• 6.2. Historical and Forecast Data Analysis By Indication
• 6.3. Oncology Historic and Forecast Sales By Regions
• 6.4. CNS Disorders Historic and Forecast Sales By Regions
• 6.5. Immunology Historic and Forecast Sales By Regions
• 6.6. Respiratory Diseases Historic and Forecast Sales By Regions
• 6.7. Genetic Disorders Historic and Forecast Sales By Regions
• 6.8. Skin Diseases Historic and Forecast Sales By Regions
• 6.9. Other Indications Historic and Forecast Sales By Regions

7. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY TECHNOLOGY

• 7.1. Overview By Technology
• 7.2. Historical and Forecast Data Analysis By Technology
• 7.3. Genomics Historic and Forecast Sales By Regions
• 7.4. Bioinformatics Historic and Forecast Sales By Regions
• 7.5. Big Data Analytics Historic and Forecast Sales By Regions
• 7.6. Biomarker Detection Historic and Forecast Sales By Regions
• 7.7. High Throughput Screening Historic and Forecast Sales By Regions
• 7.8. Other Technologies Historic and Forecast Sales By Regions

8. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY END-USER

• 8.1. Overview By End-User
• 8.2. Historical and Forecast Data Analysis By End-User
• 8.3. Hospitals Historic and Forecast Sales By Regions
• 8.4. Diagnostic Laboratories Historic and Forecast Sales By Regions
• 8.5. Other End-Users Historic and Forecast Sales By Regions

9. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PRECISION MEDICINE COMPANIES

• 10.1. Precision Medicine Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF PRECISION MEDICINE INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Abbott Laboratories Inc.
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Abbie Inc.
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. AstraZeneca Plc
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. BioMerieux SA
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Bristol-Myers Squibb Company
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Cepheid (Danaher Corporation)
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. EliLilly & Company
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. F. Hoffmann-La Roche
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. GlaxoSmithKline Plc
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Laboratory Corporation Of America Holdings (Covance Inc.)
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments
• 11.13. Myriad Genetics Inc.
  • 11.13.1 Company Overview
  • 11.13.2 Company Revenue
  • 11.13.3 Products
  • 11.13.4 Recent Developments
• 11.14. Novartis AG
  • 11.14.1 Company Overview
  • 11.14.2 Company Revenue
  • 11.14.3 Products
  • 11.14.4 Recent Developments
• 11.15. Pfizer Inc.
  • 11.15.1 Company Overview
  • 11.15.2 Company Revenue
  • 11.15.3 Products
  • 11.15.4 Recent Developments
• 11.16. QIAGEN NV.
  • 11.16.1 Company Overview
  • 11.16.2 Company Revenue
  • 11.16.3 Products
  • 11.16.4 Recent Developments
• 11.17. Quest Diagnostics
  • 11.17.1 Company Overview
  • 11.17.2 Company Revenue
  • 11.17.3 Products
  • 11.17.4 Recent Developments
• 11.18. Takeda Pharmaceutical Company Limited
  • 11.18.1 Company Overview
  • 11.18.2 Company Revenue
  • 11.18.3 Products
  • 11.18.4 Recent Developments
• 11.19. ThermFisher Scientific Inc.
  • 11.19.1 Company Overview
  • 11.19.2 Company Revenue
  • 11.19.3 Products
  • 11.19.4 Recent Developments
• 11.20. Vyant Bio Inc. (Cancer Genetics Inc.)
  • 11.20.1 Company Overview
  • 11.20.2 Company Revenue
  • 11.20.3 Products
  • 11.20.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Application (USD MN)
• Diagnostics (Genetic Tests, Biomarker Based Tests, Esoteric Tests, Other Tests) Market Sales By Geography (USD MN)
• Therapeutics (Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, Other Therapeutics) Market Sales By Geography (USD MN)
• Analysis By Indication (USD MN)
• Oncology Market Sales By Geography (USD MN)
• CNS Disorders Market Sales By Geography (USD MN)
• Immunology Market Sales By Geography (USD MN)
• Respiratory Diseases Market Sales By Geography (USD MN)
• Genetic Disorders Market Sales By Geography (USD MN)
• Skin Diseases Market Sales By Geography (USD MN)
• Other Indications Market Sales By Geography (USD MN)
• Analysis By Technology (USD MN)
• Genomics Market Sales By Geography (USD MN)
• Bioinformatics Market Sales By Geography (USD MN)
• Big Data Analytics Market Sales By Geography (USD MN)
• Biomarker Detection Market Sales By Geography (USD MN)
• High Throughput Screening Market Sales By Geography (USD MN)
• Other Technologies Market Sales By Geography (USD MN)
• Analysis By End-User (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Diagnostic Laboratories Market Sales By Geography (USD MN)
• Other End-Users Market Sales By Geography (USD MN)
• Global Precision Medicine Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Precision Medicine Report
• Market Research Process
• Market Research Methodology
• Global Precision Medicine Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Application
• Market Attractiveness Analysis By Indication
• Market Attractiveness Analysis By Technology
• Market Attractiveness Analysis By End-User
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Application (USD MN)
• Diagnostics (Genetic Tests, Biomarker Based Tests, Esoteric Tests, Other Tests) Market Sales By Geography (USD MN)
• Therapeutics (Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, Other Therapeutics) Market Sales By Geography (USD MN)
• Global Market Analysis By Indication (USD MN)
• Oncology Market Sales By Geography (USD MN)
• CNS Disorders Market Sales By Geography (USD MN)
• Immunology Market Sales By Geography (USD MN)
• Respiratory Diseases Market Sales By Geography (USD MN)
• Genetic Disorders Market Sales By Geography (USD MN)
• Skin Diseases Market Sales By Geography (USD MN)
• Other Indications Market Sales By Geography (USD MN)
• Global Market Analysis By Technology (USD MN)
• Genomics Market Sales By Geography (USD MN)
• Bioinformatics Market Sales By Geography (USD MN)
• Big Data Analytics Market Sales By Geography (USD MN)
• Biomarker Detection Market Sales By Geography (USD MN)
• High Throughput Screening Market Sales By Geography (USD MN)
• Other Technologies Market Sales By Geography (USD MN)
• Global Market Analysis By End-User (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Diagnostic Laboratories Market Sales By Geography (USD MN)
• Other End-Users Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.